Show simple item record

dc.contributor.authorGiacco, D
dc.contributor.authorChevalier, A
dc.contributor.authorPatterson, M
dc.contributor.authorHamborg, T
dc.contributor.authorMortimer, R
dc.contributor.authorYan, F
dc.contributor.authorWebber, M
dc.contributor.authorXanthopoulou, P
dc.contributor.authorPriebe, S
dc.date.accessioned2024-10-28T13:35:12Z
dc.date.issued2021-12-13
dc.date.updated2023-10-26T07:38:01Z
dc.description.abstractIntroduction People with psychosis tend to have smaller social networks than both people in the general population and other people with long-term health conditions. Small social networks are associated with poor quality of life. Preliminary evidence suggests that coaching patients to increase their social contacts may be effective. In this study, we assessed whether structured social coaching improves the quality of life of patients with psychosis (primary outcome) compared with an active control group, receiving information on local social activities. Methods and analysis A structured social coaching intervention was developed based on the literature and refined through stakeholder involvement. It draws on principles from motivational interviewing, solution focused therapy and structured information giving. It is provided over a 6-month period and can be delivered by a range of different mental health professionals. Its effectiveness and cost-effectiveness are assessed in a randomised controlled trial, compared with an active control group, in which participants are given an information booklet on local social activities. Participants are aged 18 or over, have a primary diagnosis of a psychotic disorder (International Classification of Disease: F20–29) and capacity to provide informed consent. Participants are assessed at baseline and at 6, 12 and 18 months after individual randomisation. The primary outcome is quality of life at 6 months (Manchester Short Assessment of Quality of Life). We hypothesise that the effects on quality of life are mediated by an increase in social contacts. Secondary outcomes are symptoms, social situation and time spent in social activities. Costs and cost-effectiveness analyses will consider service use and health-related quality of life.en_GB
dc.description.sponsorshipNational Institute for Health and Care Research (NIHR)en_GB
dc.identifier.citationVol. 11, No. 1, article e050627en_GB
dc.identifier.doi10.1136/bmjopen-2021-050627
dc.identifier.grantnumberRP-PG-0615-20009en_GB
dc.identifier.urihttp://hdl.handle.net/10871/137806
dc.identifierORCID: 0000-0002-1510-3382 (Xanthopoulou, Penny)
dc.language.isoenen_GB
dc.publisherBMJ Publishing Groupen_GB
dc.rights© Author(s) (or their employer(s)) 2021. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.en_GB
dc.titleEffectiveness and cost-effectiveness of a structured social coaching intervention for people with psychosis (SCENE): trial protocolen_GB
dc.typeArticleen_GB
dc.date.available2024-10-28T13:35:12Z
dc.identifier.issn2044-6055
dc.descriptionThis is the final version. Available on open access from BMJ Publishing via the DOI in this record. en_GB
dc.identifier.journalBMJ Openen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2021-10-15
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2021-10-15
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2023-10-26T07:38:03Z
refterms.versionFCDVoR
refterms.dateFOA2024-10-28T13:35:43Z
refterms.panelAen_GB
refterms.dateFirstOnline2021-12-13


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their employer(s)) 2021. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2021. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.